Suppr超能文献

载脂蛋白A-IV中360His突变对血浆高密度脂蛋白胆固醇对膳食脂肪反应的影响。

Effect of 360His mutation in apolipoprotein A-IV on plasma HDL-cholesterol response to dietary fat.

作者信息

Jansen S, Lopez-Miranda J, Ordovas J M, Zambrana J L, Marin C, Ostos M A, Castro P, McPherson R, Lopez Segura F, Blanco A, Jimenez Pereperez J A, Perez-Jimenez F

机构信息

Lipid Research Unit, University Hospital Reina Sofia, University of Cordoba Medical School, Spain.

出版信息

J Lipid Res. 1997 Oct;38(10):1995-2002.

PMID:9374122
Abstract

In order to determine whether genetic variability of apolipoprotein (apo) A-IV is responsible for the improvement in lipid profile when dietary saturated fats are replaced by carbohydrates or monounsaturated fats, 41 healthy male subjects were studied: 33 were homozygous for the 360Gln allele and 8 were heterozygote carriers of the 360His allele. These were administered three consecutive 4-week diets. The first was a diet rich in saturated fat (SAT diet, with 38% fat, 20% saturated. This was followed by a low fat diet (NCEP-I, with < 30% fat, < 10% saturated). The final diet was rich in monounsaturated fat (MUFA diet, with 38% fat, 22% monounsaturated). There was no difference in plasma lipid and apolipoprotein levels of both groups of individuals after consuming the SAT diet. Switching from this diet to the NCEP-I diet, carriers of the 360His allele presented a greater decrease in high density lipoprotein-cholesterol (HDL-C) (-10 vs. -1 mg/dL, P < 0.004) and apoA-I levels (-19 vs. -8 mg/dL, P < 0.037). Similarly, replacement of carbohydrates by monounsaturated fats produced a greater increase in HDL-C (9 vs. 1 mg/dL, P < 0.003) and apoA-I levels (9 vs. 2 mg/dL, P < 0.036) in carriers of the 360His mutation. Lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) activities and apoA-IV levels were also measured. However, no genotype-related differences were observed for these parameters. Our results suggest that variability in HDL-C and apoA-I response to diet is, at least partially, determined by the 360His mutation of apoA-IV.

摘要

为了确定载脂蛋白(apo)A-IV的基因变异性是否是用碳水化合物或单不饱和脂肪替代膳食饱和脂肪时血脂状况改善的原因,对41名健康男性受试者进行了研究:33名是360Gln等位基因的纯合子,8名是360His等位基因的杂合子携带者。这些受试者连续接受三种为期4周的饮食。第一种是富含饱和脂肪的饮食(SAT饮食,脂肪含量38%,饱和脂肪含量20%)。接下来是低脂饮食(NCEP-I,脂肪含量<30%,饱和脂肪含量<10%)。最后一种饮食富含单不饱和脂肪(MUFA饮食,脂肪含量38%,单不饱和脂肪含量22%)。两组个体在食用SAT饮食后血浆脂质和载脂蛋白水平没有差异。从这种饮食转换到NCEP-I饮食时,360His等位基因的携带者高密度脂蛋白胆固醇(HDL-C)水平下降幅度更大(-10 vs. -1 mg/dL,P<0.004),载脂蛋白A-I水平下降幅度也更大(-19 vs. -8 mg/dL,P<0.037)。同样,用单不饱和脂肪替代碳水化合物时,360His突变携带者的HDL-C水平升高幅度更大(9 vs. 1 mg/dL,P<0.003),载脂蛋白A-I水平升高幅度也更大(9 vs. 2 mg/dL,P<0.036)。还测量了卵磷脂胆固醇酰基转移酶(LCAT)和胆固醇酯转运蛋白(CETP)活性以及载脂蛋白A-IV水平。然而,这些参数未观察到与基因型相关的差异。我们的结果表明,HDL-C和载脂蛋白A-I对饮食反应的变异性至少部分由apoA-IV的360His突变决定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验